Research, Update 8 Dec 2022

UPDATE – 09.10.2022

During the first six months of the FY22A fiscal year, the Company devoted significant efforts and resources to implement a review of the strategy setting, which now provides for a simple corporate structure without

Research, Update 8 Dec 2022

UPDATE – 13.10.2022

Revenues amounted to € 7.34 million, essentially in line with the value of € 7.21 million recorded in the first six months of last year. EBITDA Adj. amounted to € 1.73 million, with a

- Riferimento
Research, Update 8 Dec 2022

UPDATE – 17.10.2022

At the end of the first half of 2022, Revenues reached € 2.17 million, an increase of 56.3% compared to € 1.39 million of the 1H21A. EBITDA accounts for € 0.82 million, up 19.6%

Research, Update 8 Dec 2022

UPDATE – 11.10.2022

Revenues amounted to € 27.66 million, compared to a value of € 14.62 million recorded in 1H21A. EBITDA amounted to € 6.65 million, up compared to 1H21A, when it was equal to € 2.46

- Riferimento
Research, Update 8 Dec 2022

UPDATE – 03.10.2022

Revenues for 1H22A amounted to € 21.53 million. EBITDA as of 30 June 2022 amounted to € 2.60 million, with an EBITDA margin of 12.1%, showing a consistent growth compared to the end of

Research, Update 8 Dec 2022

UPDATE – 13.10.2022

The Group, in the consolidated half-year financial report as of 30 June 2022, reported that it had generated revenues of € 14.35 million, compared to a value of € 9.18 million in the first

Research, Update 8 Dec 2022

UPDATE – 29.09.2022

The value of production amounted to € 11.01 million, an increase of 20.7% compared to the value recorded on 30 June 2021, equal to € 9.12 million. EBITDA on 30 June 2022 amounted to

Research, Update 8 Dec 2022

UPDATE – 05.10.2022

The VoP in 1H22A amounted to € 23.35 million, with a sales revenues value of € 22.95 million, registering a growth of 20.7% compared to 1H21A (€ 19.34 million). EBITDA, equal to € 9.59